Transforming growth factor beta 1 (TGFβ1), associated with inflammation and lung cancer risk and the smoking-related differentially methylated gene Aryl-hydrocarbon receptor repressor (AHRR) are likewise modifiers of CF lung disease [11,65,68,69]. Here, TGFB1 is linked to lung cancer.